Experimental therapy for Prader-Willi syndrome shows promise in mice

(NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development) Drugs capable of activating silenced genes improve survival and growth outcomes in a mouse model of Prader-Willi syndrome (PWS), a rare and incurable childhood disease, according to a study funded by the National Institutes of Health (NIH).